Stoke Therapeutics, Inc. STOK Total debt

Total debt at other companies

Ionis PharmaceuticalsIONS

$262.48M-67.0%

Jazz PharmaceuticalsJAZZ

$5.4B-0.1%

Xenon PharmaceuticalsXENE

$6.42M-26.4%

Praxis Precision Medicines, Inc.PRAX

$1.09M+44.0%

CalAmpCAMP

$2.12M-73.2%

Harmony Biosciences Holdings, Inc.HRMY

$164.61M-7.2%

FAQ

What is Stoke Therapeutics, Inc.'s total debt?

Stoke Therapeutics, Inc. (STOK) reported total debt of $3.42M in Q1 2026.

How has Stoke Therapeutics, Inc.'s total debt changed year-over-year?

Stoke Therapeutics, Inc.'s total debt decreased by 42.5% year-over-year, from $5.95M to $3.42M.

What is the long-term trend for Stoke Therapeutics, Inc.'s total debt?

Over 5 years (2020 to 2025), Stoke Therapeutics, Inc.'s total debt has grown at a 29.3% compound annual growth rate (CAGR), from $1.15M to $4.15M.

What does total debt mean?

Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.